同期经导管缘对缘修复治疗继发性三尖瓣和二尖瓣反流：专家意见。
Concomitant Transcatheter Edge-to-Edge Treatment of Secondary Tricuspid and Mitral Regurgitation: An Expert Opinion.
机构信息
Cardiology Unit, IRCCS Policlinico San Donato, Milan, Italy; Università degli studi di Milano, Milan, Italy. Electronic address: https://twitter.com/antosis_93.
Division of Cardiac Surgery, Herzklinik Hirslanden, Zürich, Switzerland.
出版信息
JACC Cardiovasc Interv. 2023 Jan 23;16(2):127-139. doi: 10.1016/j.jcin.2022.11.022.
Secondary (functional) tricuspid regurgitation (sTR) is common in patients with mitral regurgitation (MR). Because combined valvular heart disease affects long-term survival, in comparison with isolated MR or tricuspid regurgitation, it is essential to offer patients adequate treatment. Despite considerable experience, no conclusive data are yet available on the prognostic impact of concomitant tricuspid valve surgery at the time of mitral valve surgery. Emerging transcatheter treatments offer the opportunity to treat both conditions (MR and sTR) simultaneously or in a stepwise fashion. This review provides a clinical overview on available data regarding the rationale for treatment of sTR in patients with relevant MR undergoing mitral transcatheter edge-to-edge repair, focusing on clinical and anatomical selection criteria.
继发性（功能性）三尖瓣反流（sTR）在二尖瓣反流（MR）患者中很常见。由于联合瓣膜性心脏病会影响长期生存，因此与单纯的 MR 或三尖瓣反流相比，为患者提供充分的治疗至关重要。尽管经验丰富，但在二尖瓣手术时同时进行三尖瓣手术对预后的影响方面，目前尚无确凿的数据。新兴的经导管治疗为同时或逐步治疗两种疾病（MR 和 sTR）提供了机会。本综述提供了关于在接受二尖瓣经导管缘对缘修复的相关 MR 患者中治疗 sTR 的可用数据的临床概述，重点是临床和解剖选择标准。
Zotero 插件